FDA Inspection
Lilly del Caribe, IncLilly del Caribe, Inc – FDA Inspection, Jul 22, 2013
Record Details
This FDA Inspection record concerns Lilly del Caribe, Inc, with an inspection on July 22, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Lilly del Caribe, Inc
- Inspection Date
- July 22, 2013
- Product Type
- Drugs
View Company Profile
ID · f9ff1cac-a5f1-46f1-a101-4a7582334a19
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 841121
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration
- 21 CFR 211.192Extent of discrepancy, failure investigations
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 212.30(a)Prevention of contamination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lilly del Caribe, Inc
8| Date | Classification | Office | Project area |
|---|---|---|---|
| January 30, 2026 | VAI | San Juan District Office | Drug Quality Assurance |
| February 16, 2024 | Not classified | San Juan District Office | |
| February 25, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 12, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 21, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lilly del Caribe, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.